1. Home
  2. BAFN vs ECOR Comparison

BAFN vs ECOR Comparison

Compare BAFN & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$8.00

Market Cap

40.6M

Sector

Finance

ML Signal

N/A

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$4.82

Market Cap

39.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
ECOR
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
39.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BAFN
ECOR
Price
$8.00
$4.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$25.50
AVG Volume (30 Days)
5.9K
57.5K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
2.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,931,000.00
$29,835,000.00
Revenue This Year
N/A
$28.61
Revenue Next Year
N/A
$41.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.90
52 Week Low
$6.40
$4.16
52 Week High
$19.75
$19.49

Technical Indicators

Market Signals
Indicator
BAFN
ECOR
Relative Strength Index (RSI) 37.72 44.41
Support Level $8.05 $4.73
Resistance Level $8.07 $5.11
Average True Range (ATR) 0.10 0.25
MACD 0.04 -0.03
Stochastic Oscillator 24.39 28.07

Price Performance

Historical Comparison
BAFN
ECOR

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: